Bioinformatics Market Dynamics: Growth, Challenges, and Opportunities
Ngày đăng: 10-10-2023 |
Ngày cập nhật: 10-10-2023
Bioinformatics Market Research, 2027
The global bioinformatics market was valued at USD 10.1 billion in 2022 and is projected to reach USD 18.7 billion by 2027, at a CAGR of 13.0% during the forecast period. The growth of the bioinformatics market is driven by the increasing public and private-sector funding for bioinformatics, growing demand for personalized medicine, increasing pharmaceutical and biotechnology R&D expenditure, and decreasing cost of genome sequencing.
To know about the assumptions considered for the study download the pdf brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=39
Bioinformatics refers to the application of computational techniques, statistical methods, and data analysis tools to analyze and interpret biological data.
Here are some key points about the bioinformatics market:
Genomics and NGS: Genomic sequencing, especially NGS, has been a major driver of the bioinformatics market. The ability to sequence entire genomes quickly and cost-effectively has led to a surge in demand for bioinformatics tools and services to analyze and make sense of the vast amount of genetic data.
Drug Discovery: Bioinformatics tools are essential in drug discovery and development. They are used to identify potential drug targets, predict drug interactions, and analyze the effects of candidate drugs on biological systems.
Personalized Medicine: The concept of personalized medicine, tailoring medical treatment to individual genetic profiles, relies heavily on bioinformatics for analyzing patient-specific genomic data.
Data Analysis Software: Numerous companies have emerged in the bioinformatics sector, offering specialized software tools and platforms for data analysis, genome annotation, and interpretation of biological data.
Cloud-Based Solutions: Cloud-based bioinformatics solutions have become increasingly popular, allowing researchers to access powerful computational resources and analysis tools remotely.
Collaboration and Integration: Bioinformatics often involves collaboration between biologists, bioinformaticians, and data scientists.
Regulatory Environment: As the bioinformatics field grows, there may be increasing regulatory scrutiny, especially regarding data security, privacy, and the validation of computational methods in the context of clinical applications.
Key Market Players
Some of the prominent players operating in the bioinformatics market are Thermo Fisher Scientific, Inc. (US), Eurofins Scientific (Luxembourg), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (US), and Illumina, Inc. (US), Waters Corporation (US), DNASTAR (US), NeoGenomics Laboratories (US), Perkin Elmer, Inc. (US), GENEWIZ (US) and BGI Group (China), DNASTAR (US), Partek Incorporated (US), SOPHiA Genetics (Switzerland), Source BioScience (UK), and Biomax Informatics AG (Germany) among others.
Thermo Fisher Scientific, Inc. is the leading player in the bioinformatics market. The company mainly develops technologically advanced bioinformatics solutions to outstand its offerings. It invests into organic and inorganic growth strategies like acquisitions to strengthen its market presence.
PerkinElmer is one of the leading players in the global bioinformatics market. The company provides data analytics, computing, and scientific application software services. PerkinElmer competes in this market based on services offered, price, technological innovation, operational efficiency, product differentiation, product availability, quality, and reliability.
Illumina, Inc. is holds strong position in the bioinformatics market. Illumina has a wide range of product and service portfolio for the end users in this market, a well-established distribution network, and has geographic presence worldwide.
North America dominated the bioinformatics market is expected to grow at an 12.7% CAGR during the forecast period.
The North America holds large share in the global bioinformatics market owing to factors such as government support for genomic research, presence of top key players in the region, reduced cost of sequencing, increased awareness of bioinformatics services, and increased number of genomic research activities (and the corresponding adoption of bioinformatics) in the region are driving the growth of the bioinformatics market in North America.
Bioinformatics Market Dynamics:
Drivers:
1. Increasing public-private sector funding for bioinformatics
2. Increasing demand for personalized medicine
3. Increasing pharmaceutical and biotechnology R&D expenditure
4. Decreasing costs of genome sequencing
Restraints:
1. High equipment costs
Opportunities:
1. Lucrative opportunities in emerging markets
2. Adoption of blockchain technology and cloud computing
3. Integration of machine learning and AI in healthcare
4. Investments by leading IT companies in the development of bioinformatics solutions
Challenges:
1. Management of large data volumes
2. Lack of interoperability and multiplatform capabilities
3. Growing competition from in-house development and publicly available tools
4. Shortage of skilled bioinformatics professionals
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
The global bioinformatics market was valued at USD 10.1 billion in 2022 and is projected to reach USD 18.7 billion by 2027, at a CAGR of 13.0% during the forecast period. The growth of the bioinformatics market is driven by the increasing public and private-sector funding for bioinformatics, growing demand for personalized medicine, increasing pharmaceutical and biotechnology R&D expenditure, and decreasing cost of genome sequencing.
To know about the assumptions considered for the study download the pdf brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=39
Bioinformatics refers to the application of computational techniques, statistical methods, and data analysis tools to analyze and interpret biological data.
Here are some key points about the bioinformatics market:
Genomics and NGS: Genomic sequencing, especially NGS, has been a major driver of the bioinformatics market. The ability to sequence entire genomes quickly and cost-effectively has led to a surge in demand for bioinformatics tools and services to analyze and make sense of the vast amount of genetic data.
Drug Discovery: Bioinformatics tools are essential in drug discovery and development. They are used to identify potential drug targets, predict drug interactions, and analyze the effects of candidate drugs on biological systems.
Personalized Medicine: The concept of personalized medicine, tailoring medical treatment to individual genetic profiles, relies heavily on bioinformatics for analyzing patient-specific genomic data.
Data Analysis Software: Numerous companies have emerged in the bioinformatics sector, offering specialized software tools and platforms for data analysis, genome annotation, and interpretation of biological data.
Cloud-Based Solutions: Cloud-based bioinformatics solutions have become increasingly popular, allowing researchers to access powerful computational resources and analysis tools remotely.
Collaboration and Integration: Bioinformatics often involves collaboration between biologists, bioinformaticians, and data scientists.
Regulatory Environment: As the bioinformatics field grows, there may be increasing regulatory scrutiny, especially regarding data security, privacy, and the validation of computational methods in the context of clinical applications.
Key Market Players
Some of the prominent players operating in the bioinformatics market are Thermo Fisher Scientific, Inc. (US), Eurofins Scientific (Luxembourg), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (US), and Illumina, Inc. (US), Waters Corporation (US), DNASTAR (US), NeoGenomics Laboratories (US), Perkin Elmer, Inc. (US), GENEWIZ (US) and BGI Group (China), DNASTAR (US), Partek Incorporated (US), SOPHiA Genetics (Switzerland), Source BioScience (UK), and Biomax Informatics AG (Germany) among others.
Thermo Fisher Scientific, Inc. is the leading player in the bioinformatics market. The company mainly develops technologically advanced bioinformatics solutions to outstand its offerings. It invests into organic and inorganic growth strategies like acquisitions to strengthen its market presence.
PerkinElmer is one of the leading players in the global bioinformatics market. The company provides data analytics, computing, and scientific application software services. PerkinElmer competes in this market based on services offered, price, technological innovation, operational efficiency, product differentiation, product availability, quality, and reliability.
Illumina, Inc. is holds strong position in the bioinformatics market. Illumina has a wide range of product and service portfolio for the end users in this market, a well-established distribution network, and has geographic presence worldwide.
North America dominated the bioinformatics market is expected to grow at an 12.7% CAGR during the forecast period.
The North America holds large share in the global bioinformatics market owing to factors such as government support for genomic research, presence of top key players in the region, reduced cost of sequencing, increased awareness of bioinformatics services, and increased number of genomic research activities (and the corresponding adoption of bioinformatics) in the region are driving the growth of the bioinformatics market in North America.
Bioinformatics Market Dynamics:
Drivers:
1. Increasing public-private sector funding for bioinformatics
2. Increasing demand for personalized medicine
3. Increasing pharmaceutical and biotechnology R&D expenditure
4. Decreasing costs of genome sequencing
Restraints:
1. High equipment costs
Opportunities:
1. Lucrative opportunities in emerging markets
2. Adoption of blockchain technology and cloud computing
3. Integration of machine learning and AI in healthcare
4. Investments by leading IT companies in the development of bioinformatics solutions
Challenges:
1. Management of large data volumes
2. Lack of interoperability and multiplatform capabilities
3. Growing competition from in-house development and publicly available tools
4. Shortage of skilled bioinformatics professionals
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
